Showing results (31-40 of 279) with videos related to
Sort By:
Pageof 28
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 17, 2018
Single 6-mg dose of rasburicase: The experience in a large academic medical centerMary Nauffal, Robert Redd, Jian Ni, et al.ACG Case Reports Journal|November 19, 2019
Colonic Wall Thickening as the First Indicator of Relapse of Acute Lymphoblastic LeukemiaKelly E Hathorn, Marlise R Luskin, Michael Travis Caton, et al.Genes, Chromosomes & Cancer|July 12, 2008
Novel SSBP2-JAK2 fusion gene resulting from a t(5;9)(q14.1;p24.1) in pre-B acute lymphocytic leukemiaJennifer L Poitras, Paola Dal Cin, Jon C Aster, et al.Clinical and Translational Science|August 20, 2020
Characterization of the Relationship of Inotuzumab Ozogamicin Exposure With Efficacy and Safety End Points in Adults With Relapsed or Refractory Acute Lymphoblastic LeukemiaJoseph Chen, May Haughey, Erik Vandendries, et al.Clinical Lymphoma, Myeloma & Leukemia|January 8, 2014
Impact of timely switching from imatinib to a second-generation tyrosine kinase inhibitor after 12-month complete cytogenetic response failure: a chart review analysisDaniel J DeAngelo, Lei Chen, Annie Guerin, et al.Blood Advances|September 2, 2021
Racial and ethnic enrollment disparities and demographic reporting requirements in acute leukemia clinical trialsAndrew Hantel, Marlise R Luskin, Jacqueline S Garcia, et al.Leukemia Research|January 3, 2015
Low efficacy and high mortality associated with clofarabine treatment of relapsed/refractory acute myeloid leukemia and myelodysplastic syndromesDaniel A Roberts, Martha Wadleigh, Anne M McDonnell, et al.American Journal of Hematology|August 30, 2008
Low dose interleukin-2 following intensification therapy with high dose cytarabine for acute myelogenous leukemia in first complete remissionRichard M Stone, Daniel J DeAngelo, Anna Janosova, et al.Blood|July 7, 2005
Gefitinib induces myeloid differentiation of acute myeloid leukemiaKimberly Stegmaier, Steven M Corsello, Kenneth N Ross, et al.Expert Opinion on Therapeutic Targets|January 12, 2011
Targeting protein neddylation: a novel therapeutic strategy for the treatment of cancerMeng Wang, Bruno C Medeiros, Harry P Erba, et al.Pageof 28